Koreheal

Koreheal is an orally administered therapeutic product developed and marketed by Rowez Life Sciences, primarily composed of *Cissus quadrangularis* extract. It is utilized to accelerate the healing process of bone fractures and to manage symptoms associated with joint disorders such as osteoarthritis and osteoporosis. The active constituents of the extract, particularly ketosteroids, are believed to promote bone health by stimulating osteoblastogenesis, increasing the synthesis of collagen, and enhancing the mineralization of the bone matrix. Additionally, Koreheal exhibits anti-inflammatory and analgesic properties, which help in reducing pain and swelling associated with musculoskeletal injuries. It is standardized for its ketosteroid content to ensure consistent therapeutic efficacy.

Brand names

Koreheal

Other names

Cissus quadrangularis extract